May 3, 2024
TOPLINE: iGlarLixi, a fixed-ratio combination of insulin glargine and the glucagon-like peptide-1 receptor agonist (GLP-1 RA) lixisenatide, improves glycemic control, with a low rate of hypoglycemia, […]
May 3, 2024
TOPLINE: The microbial makeup of the small bowel is significantly and specifically altered in adults with overweight or obesity, which may represent therapeutic targets for future […]
May 2, 2024
TOPLINE: In contrast to earlier findings in young lean individuals, dietary n-6 polyunsaturated fat acid (PUFA) doesn’t promote greater lean tissue accumulation than saturated fat acid […]
May 2, 2024
TOPLINE: Differences in prodromal or early symptoms of mpox between White non-Hispanic patients and patients of color suggest healthcare disparities in vulnerable populations. METHODOLOGY: There is […]
May 2, 2024
TOPLINE: The use of methotrexate (MTX) in patients with dermatomyositis (DM) did not increase their risk for interstitial lung disease (ILD) in a cohort study. METHODOLOGY: […]
May 2, 2024
TOPLINE: The ED visits among heart transplant (HT)-recipients have increased over past decade, with infection as the main diagnosis. The mortality rate, however, remains low. METHODOLOGY: […]
May 2, 2024
TOPLINE: Psychological distress among first-time fathers is higher for those whose partners give birth to stillborn infants, those with major congenital abnormalities, or who induce an […]
May 2, 2024
TOPLINE: After adjustments, the likelihood of asthma attacks was 1.06 times higher for every 5-cm increase in waist circumference in adults with asthma. METHODOLOGY: Previous research […]
May 2, 2024
TOPLINE: The risk for cardiovascular diseases (CVDs) is lower in patients with seropositive rheumatoid arthritis (RA) who remain on stable disease-modifying antirheumatic drug (DMARD) therapy than […]